Balance Sheet Data

Idera Pharmaceuticals, Inc. (IDRA)

$0.3671

+0.02 (+4.41%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 112.6371.4342.7937.7332.55262.33383.16559.65817.441,193.97
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.331.130.460.330.573.475.077.4010.8115.80
Accounts Payable (%)
Capital Expenditure -0.21-0.07-0.01-0.01-0.27-0.40-0.58-0.85-1.24-1.81
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.